Protara Therapeutics TARA
NASDAQ TARA
$2.33 -0.11 (-4.51%)
At close: Oct 23, 2026 · 4:00 PM EDT

Protara Therapeutics (TARA) Cash & Current Investments (2013 - 2026)

Updated

Protara Therapeutics (TARA) recorded Cash & Current Investments of $142.49 million in Q2 2026, up 16.6% from $122.22 million a year earlier and up 4.9% from the prior quarter.

Analysis

Protara Therapeutics (TARA) Cash & Current Investments (2013 - 2026) Analysis & Trends

At the end of FY2025, Protara Therapeutics reported Cash & Current Investments of $155.55 million, down 8.7% from FY2024.

  • Annual Cash & Current Investments has a five-year compound annual growth rate of -1.6% (FY2020 to FY2025).
  • Across earlier years, Cash & Current Investments came in at $170.29 million in FY2024 (+159.7%), $65.58 million in FY2023 (-22.3%), $84.37 million in FY2022 (-7.5%) and $91.23 million in FY2021 (-45.9%).
  • Quarterly Cash & Current Investments has ranged from $55.22 million in Q1 2024 to $170.29 million in Q4 2024 over the past five years.
  • On a year-over-year basis, Cash & Current Investments rose in seven of the last eight quarters, with growth averaging 51.4%.
  • Peak year-over-year performance for Cash & Current Investments in the last five years was growth of 159.7% in Q4 2024, against a decline of 45.9% in Q4 2021 at the low end.
  • Per Business Quant, the preceding three quarters came in at $135.79 million (Q1 2026), $155.55 million (Q4 2025) and $132.67 million (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash & Current Investments (Qtr)
1 Eli Lilly 1,137.66 Bn 1,106.24 Bn 19.71 Bn 8.95 Bn
2 Johnson & Johnson 636.13 Bn 556.00 Bn 17.30 Bn 17.23 Bn
3 AbbVie 505.28 Bn 478.39 Bn 12.70 Bn 6.57 Bn
4 Merck 358.10 Bn 312.48 Bn 12.21 Bn 7.14 Bn
5 Novartis Ag 292.59 Bn 256.58 Bn 11.24 Bn 7.69 Bn
6 Astrazeneca 265.81 Bn 239.50 Bn 12.86 Bn 4.90 Bn
7 Amgen 237.53 Bn 192.93 Bn 7.24 Bn 13.99 Bn
8 Gilead Sciences 194.67 Bn 168.86 Bn 6.22 Bn 3.18 Bn
9 Pfizer 171.17 Bn 117.82 Bn 10.94 Bn 11.70 Bn
10 Protara Therapeutics 142.76 Mn -423.75 Mn - 142.49 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 142.49 Mn
Mar 31, 2026 135.79 Mn
Dec 31, 2025 155.55 Mn
Sep 30, 2025 132.67 Mn
Jun 30, 2025 122.22 Mn
Mar 31, 2025 124.36 Mn
Dec 31, 2024 170.29 Mn
Sep 30, 2024 81.50 Mn
Jun 30, 2024 89.58 Mn
Mar 31, 2024 55.22 Mn
Dec 31, 2023 65.58 Mn
Sep 30, 2023 74.03 Mn
Jun 30, 2023 80.36 Mn
Mar 31, 2023 86.61 Mn
Dec 31, 2022 84.37 Mn
Sep 30, 2022 96.32 Mn
Jun 30, 2022 98.46 Mn
Mar 31, 2022 87.59 Mn
Dec 31, 2021 91.23 Mn
Sep 30, 2021 93.76 Mn
API Access

Protara Therapeutics Cash & Current Investments API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=cash-and-current-investments&ticker=TARA&period=max&api_key=YOUR_API_KEY